Pds biotechnology announces conference call and webcast to present third-quarter 2021 financial results

Florham park, n.j., oct. 13, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies based on the company's proprietary versamune® t-cell activating technology, will release financial results for the third quarter of 2021 on wednesday, november 10, 2021, before the market opens. following the release, management will host a conference call to review the company's financial results and provide a business update.
PDSB Ratings Summary
PDSB Quant Ranking